Neuros (Healthcare Technology Systems) Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$25M
- Investors
-
27
Neuros (Healthcare Technology Systems) General Information
Description
Developer of neuromodulation technology designed for the development of proprietary therapies for unmet needs in patients worldwide. The company's technology delivers a high-frequency electrical signal to sensory nerves in the peripheral nervous system to block the pain signal and helps in the treatment of chronic pain in a variety of applications including post-amputation pain, chronic post-surgical pain and chronic migraine, enabling patients to get relief from their pains at an affordable price.
Contact Information
Website
www.neurosmedical.comCorporate Office
- 26800 Aliso Viejo Parkway
- Suite 250
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 26800 Aliso Viejo Parkway
- Suite 250
- Aliso Viejo, CA 92656
- United States
Neuros (Healthcare Technology Systems) Timeline
Neuros (Healthcare Technology Systems) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series C) | 01-Nov-2023 | $25M | Completed | Generating Revenue | ||
| 11. Debt - General | 10-Aug-2023 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 01-Aug-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series BB) | 07-Jan-2021 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 01-May-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series AA) | 22-Oct-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series AA) | 03-Aug-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 04-Apr-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A1) | 22-Jan-2013 | $2.51M | $7.29M | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A1) | 22-Nov-2011 | $3.5M | $4.79M | Completed | Generating Revenue |
Neuros (Healthcare Technology Systems) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series BB | ||||||||
| Series AA | ||||||||
| Junior Class 2 | 5,035,200 | $0.000100 | $0.03 | $0.47 | $0.47 | 1x | $0.47 | 1.94% |
| Junior Class 1 | 888,569 | $0.000100 | $0.18 | $2.95 | $2.95 | 1x | $2.95 | 0.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Neuros (Healthcare Technology Systems) Comparisons
Industry
Financing
Details
Neuros (Healthcare Technology Systems) Competitors (20)
One of Neuros (Healthcare Technology Systems)’s 20 competitors is MicroTransponder, a Venture Capital-Backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MicroTransponder | Venture Capital-Backed | Austin, TX | ||||
| Mainstay Medical | Venture Capital-Backed | San Diego, CA | ||||
| Theranica | Venture Capital-Backed | Netanya, Israel | ||||
| Saluda Medical | Private Equity-Backed | Artarmon, Australia | ||||
| Spark Biomedical | Venture Capital-Backed | Dallas, TX |
Neuros (Healthcare Technology Systems) Patents
Neuros (Healthcare Technology Systems) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021219722-A1 | System and method for quantifying qualitative patient-reported data sets | Pending | 11-Feb-2020 | ||
| US-20210244952-A1 | System and method for quantifying qualitative patient-reported data sets | Active | 11-Feb-2020 | ||
| EP-4103267-A1 | System and method for quantifying qualitative patient-reported data sets | Pending | 11-Feb-2020 | ||
| US-11878172-B2 | System and method for quantifying qualitative patient-reported data sets | Active | 11-Feb-2020 | ||
| EP-4103267-A4 | System and method for quantifying qualitative patient-reported data sets | Pending | 11-Feb-2020 | A61N1/36071 |
Neuros (Healthcare Technology Systems) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neuros (Healthcare Technology Systems) Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JobsOhio Growth Capital | Venture Capital | Minority | ||
| Trinity Capital | Asset Manager | Minority | ||
| Amzak Health | Venture Capital | Minority | ||
| Christopher Greenwell | Angel (individual) | Minority | ||
| InCube Ventures | Corporate Venture Capital | Minority |
Neuros (Healthcare Technology Systems) FAQs
-
When was Neuros (Healthcare Technology Systems) founded?
Neuros (Healthcare Technology Systems) was founded in 2008.
-
Where is Neuros (Healthcare Technology Systems) headquartered?
Neuros (Healthcare Technology Systems) is headquartered in Aliso Viejo, CA.
-
What is the size of Neuros (Healthcare Technology Systems)?
Neuros (Healthcare Technology Systems) has 45 total employees.
-
What industry is Neuros (Healthcare Technology Systems) in?
Neuros (Healthcare Technology Systems)’s primary industry is Therapeutic Devices.
-
Is Neuros (Healthcare Technology Systems) a private or public company?
Neuros (Healthcare Technology Systems) is a Private company.
-
What is the current valuation of Neuros (Healthcare Technology Systems)?
The current valuation of Neuros (Healthcare Technology Systems) is .
-
What is Neuros (Healthcare Technology Systems)’s current revenue?
The current revenue for Neuros (Healthcare Technology Systems) is .
-
How much funding has Neuros (Healthcare Technology Systems) raised over time?
Neuros (Healthcare Technology Systems) has raised $108M.
-
Who are Neuros (Healthcare Technology Systems)’s investors?
JobsOhio Growth Capital, Trinity Capital, Amzak Health, Christopher Greenwell, and InCube Ventures are 5 of 27 investors who have invested in Neuros (Healthcare Technology Systems).
-
Who are Neuros (Healthcare Technology Systems)’s competitors?
MicroTransponder, Mainstay Medical, Theranica, Saluda Medical, and Spark Biomedical are some of the 20 competitors of Neuros (Healthcare Technology Systems).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
